Commitment, dedication and passion are attributes that show through in every aspect of care at Regional Cancer Care Associates. They are the building blocks for success, and why RCCA physicians are routinely selected as the top in their field.
These qualities are just part of why 19 doctors from RCCA were named 2024 Top Cancer Doctors as selected by health care research and information company Castle Connolly. Using an exhaustive and independent process of peer nomination, research, review and screening, the company has a reputation as America’s trusted source for finding top doctors.
Combined with a uniquely personal approach, cutting-edge therapies and sophisticated diagnostics, physicians at Regional Cancer Care Associates’ 16 New Jersey locations deliver state-of-the-art care in an environment that is supportive and hopeful.
Importantly, RCCA is able to deliver this care close to a patient’s home, easing the burden for those who would rather not travel to New York or Philadelphia. Loved ones can instead focus on providing support and strength, while patients can focus on healing. Additionally, a Journal of Clinical Oncology showed that receiving cancer care close to home reduces hospitalizations.
The physicians named to Castle Connolly’s prestigious list of 2024 Top Cancer Doctors in New Jersey are:
Of the 850,000 practicing physicians in the U.S., just 7% are named to the Top Doctors list. The recognition is given following a comprehensive review process conducted by an experienced medical review board. Reviewers consider a doctor’s skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients.
RCCA has more than 90 cancer specialists who treat patients at more than 20 RCCA care centers in New Jersey, Connecticut, Maryland and the Washington, D.C., area. Those oncologists see more than 23,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians.
RCCA is the top choice of many patients due to the comprehensive services offered by its physicians, including immunotherapies and targeted therapy. Patients also have access to a range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions — including multiple sclerosis, Crohn’s disease, asthma, and rheumatoid arthritis — who take intravenously administered medications.
To learn more about RCCA, call 844-928-0089 or visit RCCA.com.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Bhavesh Balar, MD, says that a dramatic increase in cancer treatment options and the prolonged survival those regimens are providing lend new urgency to an old challenge: effective communication between oncologists and their patients’ other physicians.
With care centers in New Jersey, Connecticut, Maryland, Massachusetts and the Washington, D.C., area, thousands of patients each year have come to rely on the expertise, dedication and compassion of Regional Cancer Care Associates.
More than 80 medical oncologists and hematologists affiliated with Regional Cancer Care Associates (RCCA) – one of the nation’s largest networks of oncology specialists — are on the frontlines of the fight against cancer in New Jersey, providing care to well over 100,000 people each year in 19 community-based practices across the Garden State.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
